Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-18-001227
Filing Date
2018-05-08
Accepted
2018-05-08 08:17:30
Documents
46
Period of Report
2018-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gala_10q-022818.htm 10-Q 207882
2 CERTIFICATION gala_10q-ex3101.htm EX-31.1 9887
3 CERTIFICATION gala_10q-ex3201.htm EX-32.1 4405
  Complete submission text file 0001683168-18-001227.txt   1584417

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE glag-20180228.xml EX-101.INS 221629
5 XBRL SCHEMA FILE glag-20180228.xsd EX-101.SCH 23159
6 XBRL CALCULATION FILE glag-20180228_cal.xml EX-101.CAL 44236
7 XBRL DEFINITION FILE glag-20180228_def.xml EX-101.DEF 44095
8 XBRL LABEL FILE glag-20180228_lab.xml EX-101.LAB 168076
9 XBRL PRESENTATION FILE glag-20180228_pre.xml EX-101.PRE 130583
Mailing Address 18881 VON KARMAN AVE. SUITE 1440 IRVINE CA 92612
Business Address 18881 VON KARMAN AVE. SUITE 1440 IRVINE CA 92612 949-851-9261
Gala Pharmaceuticals Inc. (Filer) CIK: 0001513403 (see all company filings)

EIN.: 421771014 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 333-172744 | Film No.: 18813041
SIC: 2300 Apparel & Other Finishd Prods of Fabrics & Similar Matl